Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 4
Submit an article Journal homepage
403
Views
50
CrossRef citations to date
0
Altmetric
Reviews

Oncolytic measles virus strains as novel anticancer agents

Pavlos MsaouelAlbert Einstein College of Medicine, Jacobi Medical Center, Department of Internal Medicine, Bronx, NY, USA
, MD PhD,
Mateusz OpyrchalDivision of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
, MD PhD,
Evidio Domingo MusibayDivision of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
, MD &
Evanthia GalanisDivision of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA;Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA+507 2843902; +507 284 1803; [email protected]
, MD
Pages 483-502 | Published online: 06 Jan 2013

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Maria Luisa Varela, Andrea Comba, Syed M Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria G Castro & Pedro R Lowenstein. (2023) Gene Therapy for High Grade Glioma: The Clinical Experience. Expert Opinion on Biological Therapy 23:2, pages 145-161.
Read now
Aline Baldo, Evanthia Galanis, Frédéric Tangy & Philippe Herman. (2016) Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination. Human Vaccines & Immunotherapeutics 12:5, pages 1102-1116.
Read now
Slawomir Antoszczyk & Samuel D. Rabkin. (2016) Prospects and progress of oncolytic viruses for treating peripheral nerve sheath tumors. Expert Opinion on Orphan Drugs 4:2, pages 129-138.
Read now
Hussein Y Naim. (2015) Measles virus. Human Vaccines & Immunotherapeutics 11:1, pages 21-26.
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:6.
Read now

Articles from other publishers (45)

Sheela Onnockx, Aline Baldo & Katia Pauwels. (2023) Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment. Vaccines 11:9, pages 1448.
Crossref
Viktoria Mayer, Anna‐Carina Frank, Shirin Preinsperger, Patrick Csar, Petra Steppert, Alois Jungbauer & Patricia Pereira Aguilar. (2023) Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus. Biotechnology Progress 39:4.
Crossref
Rui Ma, Zhenlong Li, E. Antonio Chiocca, Michael A. Caligiuri & Jianhua Yu. (2023) The emerging field of oncolytic virus-based cancer immunotherapy. Trends in Cancer 9:2, pages 122-139.
Crossref
Qiang Wen & Bin Liu. (2023) Global boundedness in an oncolytic virotherapy model with generalized logistic source. Zeitschrift für angewandte Mathematik und Physik 74:1.
Crossref
Qian Zhao & Bin Liu. (2022) Dampening effects on global boundedness in a quartic haptotactic model with fusogenic oncolytic virus and syncytia. Zeitschrift für angewandte Mathematik und Physik 73:6.
Crossref
Anastasiya V. Semenova, Galina F. Sivolobova, Antonina A. Grazhdantseva, Alexander P. Agafonov & Galina V. Kochneva. (2022) Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses. Acta Naturae 14:3, pages 46-56.
Crossref
Karina Spunde, Ksenija Korotkaja & Anna Zajakina. (2022) Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. Biomedicines 10:9, pages 2142.
Crossref
Ya-nan Wei, Yifu Wang & Jing Li. (2022) Asymptotic behavior for solutions to an oncolytic virotherapy model involving triply haptotactic terms. Zeitschrift für angewandte Mathematik und Physik 73:2.
Crossref
Guoqiang Ren & Jinlong Wei. (2021) Analysis of a two-dimensional triply haptotactic model with a fusogenic oncolytic virus and syncytia. Zeitschrift für angewandte Mathematik und Physik 72:4.
Crossref
Guoqiang Ren & Bin Liu. (2021) Global classical solvability in a three‐dimensional haptotaxis system modeling oncolytic virotherapy. Mathematical Methods in the Applied Sciences 44:11, pages 9275-9291.
Crossref
Aline Baldo, Amaya Leunda, Nicolas Willemarck & Katia Pauwels. (2021) Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2. Vaccines 9:5, pages 453.
Crossref
Ianko D. Iankov, Cheyne Kurokawa, Kimberly Viker, Steven I. Robinson, Arun Ammayappan, Eleni Panagioti, Mark J. Federspiel & Evanthia Galanis. (2020) Live Attenuated Measles Virus Vaccine Expressing Helicobacter pylori Heat Shock Protein A. Molecular Therapy - Oncolytics 19, pages 136-148.
Crossref
Lizhi Li, Shixin Liu, Duoduo Han, Bin Tang & Jian Ma. (2020) Delivery and Biosafety of Oncolytic Virotherapy. Frontiers in Oncology 10.
Crossref
Yuhui Zhang & Zhuoming Liu. (2020) Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status. Current Pharmaceutical Design 25:40, pages 4251-4263.
Crossref
Takafumi Hiramoto, Maino Tahara, Jiyuan Liao, Yasushi Soda, Yoshie Miura, Ryo Kurita, Hiroshi Hamana, Kota Inoue, Hiroshi Kohara, Shohei Miyamoto, Yasuki Hijikata, Shinji Okano, Yoshiyuki Yamaguchi, Yoshinao Oda, Kenji Ichiyanagi, Hidehiro Toh, Hiroyuki Sasaki, Hiroyuki Kishi, Akihide Ryo, Atsushi Muraguchi, Makoto Takeda & Kenzaburo Tani. (2020) Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells. Molecular Therapy 28:1, pages 129-141.
Crossref
Matilde Hoffman, DeGaulle I. Chigbu, Brenndan L. Crumley, Ravi Sharma, Sergey Pustylnikov, Thomas Crilley, Rashida Ginwala, Ronak Loonawat, Julie Joseph, Dominic Sales, Sydney Wilson & Pooja Jain. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control 1 120 .
Shin Kedashiro, Ayumu Sugiura, Kiyohito Mizutani & Yoshimi Takai. (2019) Nectin-4 cis-interacts with ErbB2 and its trastuzumab-resistant splice variants, enhancing their activation and DNA synthesis. Scientific Reports 9:1.
Crossref
Gabriel Scheubeck, Susanne Berchtold, Irina Smirnow, Andrea Schenk, Julia Beil & Ulrich M. Lauer. (2019) Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus. Viruses 11:7, pages 614.
Crossref
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, Ileana Aderca, Alexey A Leontovich, Matthew J Maurer, Ann L Oberg, Mark A Schroeder, Caterina Giannini, Suzanne M Greiner, Marc A Becker, E Aubrey Thompson, Paul Haluska, Mark E Jentoft, Ian F Parney, S John Weroha, Jin Jen, Jann N Sarkaria & Evanthia Galanis. (2018) Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. JNCI: Journal of the National Cancer Institute 110:10, pages 1123-1132.
Crossref
Naiara Martínez-Vélez, Candelaria Gomez-Manzano, Juan Fueyo, Ana Patiño-García & Marta M. Alonso. 2018. Gene Therapy in Neurological Disorders. Gene Therapy in Neurological Disorders 357 384 .
Sushil Kumar Sahu & Mukesh Kumar. 2018. Microbial Biotechnology. Microbial Biotechnology 361 382 .
Blake A. Jacobson, Ahad A. Sadiq, Shaogeng Tang, Joe Jay-Dixon, Manish R. Patel, Jeremy Drees, Brent S. Sorenson, Stephen J. Russell & Robert A. Kratzke. (2017) Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma. Oncotarget 8:38, pages 63096-63109.
Crossref
Jasmina Rajc, Damir Gugić, Irena Fröhlich, Ksenija Marjanović & Boris Dumenčić. (2017) Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer. Pathology - Research and Practice 213:9, pages 1102-1108.
Crossref
Aiping Chen, Yonghui Zhang, Gang Meng, Dengxu Jiang, Hailin Zhang, Meihong Zheng, Mao Xia, Aiqin Jiang, Junhua Wu, Christian Beltinger & Jiwu Wei. (2017) Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment. Scientific Reports 7:1.
Crossref
Dora Sviben, Dubravko Forcic, Jelena Ivancic-Jelecki, Beata Halassy & Marija Brgles. (2017) Recovery of infective virus particles in ion-exchange and hydrophobic interaction monolith chromatography is influenced by particle charge and total-to-infective particle ratio. Journal of Chromatography B 1054, pages 10-19.
Crossref
Sebastien Delpeut, Gary Sisson, Karen M. Black & Christopher D. Richardson. (2017) Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway. Journal of Virology 91:10.
Crossref
Justin Maroun, Miguel Muñoz-Alía, Arun Ammayappan, Autumn Schulze, Kah-Whye Peng & Stephen Russell. (2017) Designing and building oncolytic viruses. Future Virology 12:4, pages 193-213.
Crossref
Virginia Bayer, Beau Amaya, Diane Baniewicz, Colleen Callahan, Lisa Marsh & Asia McCoy. (2017) Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice. Clinical Journal of Oncology Nursing 21:2, pages 13-21.
Crossref
Masahiro Maruoka, Shin Kedashiro, Yuki Ueda, Kiyohito Mizutani & Yoshimi Takai. (2017) Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway. Journal of Biological Chemistry 292:17, pages 6895-6909.
Crossref
Rik L. de Swart. (2017) Measles: What we have learned from non-human primate models. Drug Discovery Today: Disease Models 23, pages 31-34.
Crossref
Katrin Ramsauer & Frédéric Tangy. (2016) Chikungunya Virus Vaccines: Viral Vector–Based Approaches: Table 1.. Journal of Infectious Diseases 214:suppl 5, pages S500-S505.
Crossref
Sangeet Lal, Kah-Whye Peng, Michael B. Steele, Nathan Jenks, Hong Ma, Gary Kohanbash, Joanna J. Phillips & Corey Raffel. (2016) Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice. Human Gene Therapy Clinical Development 27:4, pages 145-151.
Crossref
Hirosha Geekiyanage & Evanthia Galanis. (2016) MiR‐31 and miR‐128 regulates poliovirus receptor‐related 4 mediated measles virus infectivity in tumors. Molecular Oncology 10:9, pages 1387-1403.
Crossref
Juliane W Schott, Michael Morgan, Melanie Galla & Axel Schambach. (2016) Viral and Synthetic RNA Vector Technologies and Applications. Molecular Therapy 24:9, pages 1513-1527.
Crossref
Evidio Domingo-Musibay & Masato Yamamoto. (2016) Gene and virotherapy for hematological malignancies. International Journal of Hematology 104:1, pages 29-41.
Crossref
Zahid Delwar, Kaixin Zhang, Paul S. Rennie & William Jia. (2016) Oncolytic virotherapy for urological cancers. Nature Reviews Urology 13:6, pages 334-352.
Crossref
Youra Kim, Derek Clements, Andra Sterea, Hyun Jang, Shashi Gujar & Patrick Lee. (2015) Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy. Viruses 7:12, pages 6506-6525.
Crossref
Hokyung K Chung, Conor L Jacobs, Yunwen Huo, Jin Yang, Stefanie A Krumm, Richard K Plemper, Roger Y Tsien & Michael Z Lin. (2015) Tunable and reversible drug control of protein production via a self-excising degron. Nature Chemical Biology 11:9, pages 713-720.
Crossref
Rory de Vries, W. Duprex & Rik de Swart. (2015) Morbillivirus Infections: An Introduction. Viruses 7:2, pages 699-706.
Crossref
Stewart M Coleman & Alistair McGregor. (2015) A bright future for bioluminescent imaging in viral research. Future Virology 10:2, pages 169-183.
Crossref
Jianfang Ning & Samuel D. Rabkin. 2015. Translating Gene Therapy to the Clinic. Translating Gene Therapy to the Clinic 305 323 .
E Domingo-Musibay, C Allen, C Kurokawa, J J Hardcastle, I Aderca, P Msaouel, A Bansal, H Jiang, T R DeGrado & E Galanis. (2014) Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma. Cancer Gene Therapy 21:11, pages 483-490.
Crossref
Amy Haseley Thorne, Walter H Meisen, Luke Russell, Ji Young Yoo, Chelsea M Bolyard, Justin D Lathia, Jeremy Rich, Vinay K Puduvalli, Hsiaoyin Mao, Jianhua Yu, Michael A Caligiuri, Susheela Tridandapani & Balveen Kaur. (2014) Role of Cysteine-rich 61 Protein (CCN1) in Macrophage-mediated Oncolytic Herpes Simplex Virus Clearance. Molecular Therapy 22:9, pages 1678-1687.
Crossref
Sebastien Delpeut, Ryan Noyce & Christopher Richardson. (2014) The Tumor-Associated Marker, PVRL4 (Nectin-4), Is the Epithelial Receptor for Morbilliviruses. Viruses 6:6, pages 2268-2286.
Crossref
Evangelos Pazarentzos & Nicholas D. Mazarakis. 2014. Anticancer Genes. Anticancer Genes 255 280 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.